# H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

> **NCT06325696** · PHASE2 · RECRUITING · sponsor: **National Institute of Environmental Health Sciences (NIEHS)** · enrollment: 37 (estimated)

## Conditions studied

- Interstitial Lung Disease
- Idiopathic Pulmonary Fibrosis
- Lung Diseases, Interstitial

## Interventions

- **DRUG:** hymecromone

## Key facts

- **NCT ID:** NCT06325696
- **Lead sponsor:** National Institute of Environmental Health Sciences (NIEHS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-05
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06325696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06325696, "H01 in Adults With Interstitial Lung Disease (The SOLIS Study)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06325696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*